Two Zolgensma patients die of liver failure
On August 11, 2022, Novartis reported the death of two Zolgensma patients from liver failure. Zolgensma (onasemnogene abeparvovec), produced by AveXis, a Novartis company, is a gene therapy medicine, containing [...]